Page 333 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

Rheumatoid Arthritis Vasculitis 307

[9] Scott DG, Bacon PA. Intravenous cyclophosphamide plus methylprednisolone in
treatment of systemic rheumatoid vasculitis. Am. J. Med., 1984; 76:377-384.

[10] Watts RA, Carruthers DM, Symmons DP, et al. The incidence of rheumatoid vasculitis
in the Norwich Health Authority. Brit. J. Rheumatol., 1994; 33:832-833.

[11] Turesson C, Jacobsson L, Bergstrom U. Extra-articular rheumatoid arthritis: prevalence
and mortality. Rheumatology, 1999; 38:668-674.

[12] Turesson C, McClelland RL, Christianson TJ, et al. No decrease over time in the
incidence of vasculitis or other extra-articular manifestations in rheumatoid arthritis:
results from a community-based study. Arthritis Rheum., 2004; 50:3729-3731.

[13] Myasoedova E, Crowson CS, Turesson C, et al. Incidence of extra-articular rheumatoid
arthritis in Olmsted County, Minnesota, in 1995-2007 versus 1985-1994: a population-
based study. J. Rheumatol., 2011; 38:983-989.

[14] Bartels C, Bell C, Rosenthal A, et al. Decline in rheumatoid vasculitis prevalence
among US veterans: a retrospective cross-sectional study. Arthritis Rheum., 2009;
60:2553-2557.

[15] Watts RA, Mooney J, Lane SE, et al. Rheumatoid vasculitis: becoming extinct?
Rheumatology (Oxford), 2004; 43:920-923.

[16] Ward MM. Decreases in rates of hospitalizations for manifestations of severe
rheumatoid arthritis, 1983-2001. Arthritis Rheum., 2004; 50:1122-1131.

[17] Turesson C, Matteson EL. Extra-articular features of rheumatoid arthritis and systemic
involvement. In, Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH,
eds. Rheumatology Fifth Ed. Philadelphia, PA: Elsevier; 2011, 839-848.

[18] Turesson C, Matteson EL. Vasculitis in rheumatoid arthritis. Curr. Opin. Rheumatol.,
2009; 21:35-40.

[19] Scott DG, Bacon PA, Tribe CR. Systemic rheumatoid vasculitis: a clinical and
laboratory study of 50 cases. Medicine (Baltimore), 1981; 60:288-297.

[20] Voskuyl AE, Zwinderman AH, Westedt ML, et al. Factors associated with the
development of vasculitis in rheumatoid arthritis: results of a case-control study. Ann.
Rheum. Dis., 1996; 55:190-192.

[21] Turesson C, McClelland RL, Christianson T, Clustering of extra-articular
manifestations in patients with rheumatoid arthritis. J. Rheumatol., 2008; 35:179-180.

[22] Silman AJ, Newman J, MacGregor AJ. Cigarette smoking increases the risk of
rheumatoid arthritis. Results from a nationwide study of disease-discordant twins.
Arthritis Rheum., 1996; 39:732-735.

[23] Struthers GR, Scott DL, Delamere JP. Smoking and rheumatoid vasculitis. Rheumatol.
Int., 1981; 1:145-146.

[24] Turesson C, Schaid DJ, Weyand CM, et al. Association of HLA-C3 and smoking with
vasculitis in patients with rheumatoid arthritis. Arthritis Rheum., 2006; 54:2776-2783.

[25] Gorman JD, David-Vaudey E, Pai M, et al. Particular HLA-DRB1 shared epitope
genotypes are strongly associated with rheumatoid vasculitis. Arthritis Rheum., 2004;
50:3476-3484.

[26] Wilkinson M, Kirk J. Leg Ulcers Complicating Rheumatoid Arthritis. Scott. Med. J.,
1965; 10:175-182.

[27] Breedveld FC. Vasculitis associated with connective tissue disease. Bailliere's Clinical
Rheumatology, 1997; 11:315-334.

Complimentary Contributor Copy